Next Article in Journal
Chain-Selective Isotopic Labeling of the Heterodimeric Type III Secretion Chaperone, Scc4:Scc1, Reveals the Total Structural Rearrangement of the Chlamydia trachomatis Bi-Functional Protein, Scc4
Next Article in Special Issue
Rheumatoid Arthritis: Applicability of Ready-to-Use Human Cartilaginous Cells for Screening of Compounds with TNF-Alpha Inhibitory Activity
Previous Article in Journal
Stability Evaluation and Degradation Studies of DAC® Hyaluronic-Polylactide Based Hydrogel by DOSY NMR Spectroscopy
Previous Article in Special Issue
Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe?
Open AccessReview

DMARDs–Gut Microbiota Feedback: Implications in the Response to Therapy

1
Faculty of Chemical-Biological Sciences, PhD program in Biomedical Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero 39087, Mexico
2
Faculty of Chemical-Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero 39087, Mexico
3
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico
*
Author to whom correspondence should be addressed.
Biomolecules 2020, 10(11), 1479; https://doi.org/10.3390/biom10111479
Received: 16 September 2020 / Revised: 10 October 2020 / Accepted: 21 October 2020 / Published: 24 October 2020
(This article belongs to the Special Issue Pathogenesis of Arthritis)
Due to its immunomodulatory effects and the limitation in the radiological damage progression, disease-modifying antirheumatic drugs (DMARDs) work as first-line rheumatoid arthritis (RA) treatment. In recent years, numerous research projects have suggested that the metabolism of DMARDs could have a role in gut dysbiosis, which indicates that the microbiota variability could modify the employment of direct and indirect mechanisms in the response to treatment. The main objective of this review was to understand the gut microbiota bacterial variability in patients with RA, pre and post-treatment with DMARDs, and to identify the possible mechanisms through which microbiota can regulate the response to pharmacological therapy. View Full-Text
Keywords: DMARDs; gut microbiota; dysbiosis; rheumatoid arthritis DMARDs; gut microbiota; dysbiosis; rheumatoid arthritis
Show Figures

Graphical abstract

MDPI and ACS Style

Zaragoza-García, O.; Castro-Alarcón, N.; Pérez-Rubio, G.; Guzmán-Guzmán, I.P. DMARDs–Gut Microbiota Feedback: Implications in the Response to Therapy. Biomolecules 2020, 10, 1479. https://doi.org/10.3390/biom10111479

AMA Style

Zaragoza-García O, Castro-Alarcón N, Pérez-Rubio G, Guzmán-Guzmán IP. DMARDs–Gut Microbiota Feedback: Implications in the Response to Therapy. Biomolecules. 2020; 10(11):1479. https://doi.org/10.3390/biom10111479

Chicago/Turabian Style

Zaragoza-García, Oscar; Castro-Alarcón, Natividad; Pérez-Rubio, Gloria; Guzmán-Guzmán, Iris P. 2020. "DMARDs–Gut Microbiota Feedback: Implications in the Response to Therapy" Biomolecules 10, no. 11: 1479. https://doi.org/10.3390/biom10111479

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop